UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 4 | April 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 3
March-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2403021


Registration ID:
533507

Page Number

a140-a159

Share This Article


Jetir RMS

Title

A CLINICAL STUDY OF AMRITADI KVATH IN TAMAK SHVASA WITH SPECIAL REFERENCE TO BRONCHIAL ASTHMA .

Abstract

.According to Ayurveda, Shvasa roga is one of the main diseases of Pranvaha srotasa. Shvasa is described as disease as well as symptoms of some other diseases. In Samhita, Shvasa is classified into five types, Tamakshvasa is one of them. Acharya Charak described Tamak shvasa is a yapya type of disease. Tamakshvasa patients always suffer on & off attack repeatedly. So that patient has to depend upon medicine for reliefAcharya charak has stated shodhan & shaman chikitsa for tamakshvasa(1). Shodhan chikitsa in the form of vaman & virechana. Shodhan indicated for great degree of vitiation of doshas & in physically strong patient Shodhan treatment is not suitable for each & every patient . So Charak indicated shaman chikitsa to durabala & heen satva patients of Tamakashvasa. In Modern, Bronchial asthma has now become one of the commonest chronic diseases. In the world about 300 million people were suffered from bronchial asthma according to Harrison internal medicine (2021), prevalence of this disease 10 to 12 % in adult is increasing throughout the world. In modern science, the treatment of bronchial asthma is removal of causative factor like allergens & medicinal line of treatment. In medicinal treatment drugs such as bronchodilators, glucocorticoids, expectorants & inhalers are used. Obviously modern medicine used in status bronchial asthma is life-saving but these medicines are also used for longer duration in chronic bronchial asthma. When these drugs are used for longer duration they produce many side effects like immunosuppression, obesity, peptic ulcer & oral candidiasis. Some expectorants & Bronchodilator’s cause tremors. Patients develop unwanted effects later. Ayurveda management provides preventive as well as curative treatment for Tamak Shwas like Amritadi kwath which relieves symptoms of disease.

Key Words

TAMAK SHWAS, BRONCHIAL ASTHMA,AMRITADI KVATH

Cite This Article

"A CLINICAL STUDY OF AMRITADI KVATH IN TAMAK SHVASA WITH SPECIAL REFERENCE TO BRONCHIAL ASTHMA . ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 3, page no.a140-a159, March-2024, Available :http://www.jetir.org/papers/JETIR2403021.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A CLINICAL STUDY OF AMRITADI KVATH IN TAMAK SHVASA WITH SPECIAL REFERENCE TO BRONCHIAL ASTHMA . ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 3, page no. ppa140-a159, March-2024, Available at : http://www.jetir.org/papers/JETIR2403021.pdf

Publication Details

Published Paper ID: JETIR2403021
Registration ID: 533507
Published In: Volume 11 | Issue 3 | Year March-2024
DOI (Digital Object Identifier):
Page No: a140-a159
Country: Dharashiv, Maharashtra , India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000336

Print This Page

Current Call For Paper

Jetir RMS